- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03916237
Registry and Screening Tool to Identify Children With Asthma Likely to Benefit From Home Assessment and Remediation (CREST)
October 17, 2023 updated by: Vanessa Maier, MD, MetroHealth Medical Center
Utilizing a Clinical Registry and Environmental Screening Tool to Identify Children With Asthma Most Likely to Benefit From Home Assessment and Remediation
Recognizing a decline in pediatric primary care visits and immunizations rates, an increase in utilization of the emergency room and stagnating academic achievement, leaders of MetroHealth Medical Center and the Cleveland Metropolitan School District understood that an innovative delivery option would be required to meet the needs of their pediatric urban population.
In the fall of 2013, with support from local and regional funders, they collaborated to open the first School Based Health Center in Cleveland.
During its first year, the MetroHealth School Health Program provided primary care services to children in 98 clinical care visits.
Through an emphasis on population health and care coordination, the School Health Program has grew dramatically, completing over 2,400 visits in the 2017-2018 school year at clinical sites in over 13 schools.
The School Health Program has been successful in developing a care management model to improve the percentage of students who complete recommended preventive services including immunization and preventive visits.
The investigators intend to apply and expand upon lessons learned to develop an effective multi component asthma care management model that includes (1) registry utilization (2) evidence based clinical care protocols (3) implementation of an Environmental Screening Tool (4) effective utilization of a Medical Legal Partnership (5) effective partnership with an environmental health justice community organization, Environmental Health Watch, for home assessment and remediation (6) utilization of a unique data sharing partnership between a large health system and school district to document health and educational outcomes.
Study Overview
Status
Completed
Conditions
Detailed Description
Students enrolled in the MetroHealth School Health Program (signed parental consent on file in electronic health record) and have a diagnosis of asthma on active problem list, or were seen in Emergency Department or Express Care in past 12 months for asthma related diagnosis, or have a rescue or controller inhaled medication on current medication list, will be considered for inclusion.
Research staff will call families who meet inclusion criteria to discuss the study, determine interest in inclusion and obtain consent.
Once enrolled baseline measures will be obtained, including level of asthma control and responses on the Environmental Screening Tool (EST) and the Community Advocacy Program Home Asthma Screening Tool (CAPHAST) (see CREST phone screening tool).
Participants will then be randomized into two groups.
The first group will receive regular care.
The second group will receive the Asthma Home Assessment Intervention.
Based on results of the screening tool and home assessments, participants will be placed into one of four groups (see CREST study design): GROUP A (no referral) GROUP B (home assessment only) GROUP C (home assessment and remediation) and GROUP D (medical legal partnership referral only) Participants randomized to regular care will be assessed for outcome measures at 3 and 6 months after randomization.
Those randomized to the intervention arm will be assessed at 3 and 6 months after completion of intervention.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44109
- MetroHealth Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 15 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Enrolled in the MetroHealth School Health Program (signed parental consent on file in Epic electronic health record)
- Has diagnosis of asthma on active problem list OR was seen in Emergency Department or Express Care in past 12 months for asthma related diagnosis, OR has asthma related rescue or controller inhaled medication on current medication list.
Exclusion Criteria:
• Does not meet inclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: CONTROL
Control group
|
|
Experimental: GROUP A no referral
Screener does not document need for home visit or medical legal partnership referral.
|
Regular care in the School Health Program
|
Experimental: GROUP B1 home assessment only
Screener documents need for home assessment.
Home assessment does not document need for home remediation.
Screener does not document need for medical legal partnership.
|
Home assessment for environmental hazards according to protocol established by Environmental Health Watch (Healthy Home Audit https://www.ehw.org/healthy-home-audit/)
|
Experimental: GROUP B2 home assessment only
Screener documents need for home assessment.
Home assessment does not document need for home remediation.
Screener documents need for medical legal partnership.
|
Home assessment for environmental hazards according to protocol established by Environmental Health Watch (Healthy Home Audit https://www.ehw.org/healthy-home-audit/)
Medical Legal Partnership referral as described by the National Center for Medical Legal partnerships and others (Beck AF, Identifying and treating a substandard housing cluster using a medical-legal partnership.
Pediatrics.
2012;130(5):831-838)
|
Experimental: GROUP C1 home assessment and remediation
Screener documents need for home assessment.
Home assessment documents need for home remediation.
Screener does not document need for medical legal partnership.
|
Home assessment for environmental hazards according to protocol established by Environmental Health Watch (Healthy Home Audit https://www.ehw.org/healthy-home-audit/)
Low level home remediation according to previously established protocol (Kercsmar CM, Dearborn DG, Schluchter M, et al.
Reduction in asthma morbidity in children as a result of home remediation aimed at moisture sources.
Environ Health Perspect.
2006;114(10):1574-80)
|
Experimental: GROUP C2 home assessment and remediation
Screener documents need for home assessment.
Home assessment documents need for home remediation.
Screener documents need for medical legal partnership.
|
Home assessment for environmental hazards according to protocol established by Environmental Health Watch (Healthy Home Audit https://www.ehw.org/healthy-home-audit/)
Medical Legal Partnership referral as described by the National Center for Medical Legal partnerships and others (Beck AF, Identifying and treating a substandard housing cluster using a medical-legal partnership.
Pediatrics.
2012;130(5):831-838)
Low level home remediation according to previously established protocol (Kercsmar CM, Dearborn DG, Schluchter M, et al.
Reduction in asthma morbidity in children as a result of home remediation aimed at moisture sources.
Environ Health Perspect.
2006;114(10):1574-80)
|
Experimental: D medical legal partnership only
Screener does not document need for home assessment.
Screener does not document need for medical legal partnership.
|
Medical Legal Partnership referral as described by the National Center for Medical Legal partnerships and others (Beck AF, Identifying and treating a substandard housing cluster using a medical-legal partnership.
Pediatrics.
2012;130(5):831-838)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Asthma Control Test Score
Time Frame: baseline and 3 and 6 months after intervention
|
Score on: Asthma Control Test (for children 12 and over) or Child Asthma Control Test (for children under 12) The Asthma Control Test is used to identify asthma control with scores ranging from a minimum of 5 (poor control) to a maximum of 25 (complete control) A score of over 19 indicated well controlled asthma.
|
baseline and 3 and 6 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in number of Asthma Related Emergency Department Visits
Time Frame: baseline and 3 and 6 months after intervention
|
Self reported number of asthma related emergency department visits in past 4 months
|
baseline and 3 and 6 months after intervention
|
Change in number of Asthma Related Hospitalizations
Time Frame: baseline and 3 and 6 months after intervention
|
Self reported number of asthma related hospitalizations in past 4 months
|
baseline and 3 and 6 months after intervention
|
Change in number of Asthma related Express Care or Urgent Care visits
Time Frame: baseline and 3 and 6 months after intervention
|
Self reported number of asthma related Express Care or Urgent Care visits in past 4 months
|
baseline and 3 and 6 months after intervention
|
Educational Outcome: attendance
Time Frame: in past 3 months
|
number of absences
|
in past 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Vanessa Maier, MD, MPH, MetroHealth Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2019
Primary Completion (Actual)
January 1, 2023
Study Completion (Actual)
June 1, 2023
Study Registration Dates
First Submitted
April 11, 2019
First Submitted That Met QC Criteria
April 12, 2019
First Posted (Actual)
April 16, 2019
Study Record Updates
Last Update Posted (Actual)
October 19, 2023
Last Update Submitted That Met QC Criteria
October 17, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB18-00771
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsNot yet recruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma Chronic
-
Johann Wolfgang Goethe University HospitalCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Universita di VeronaCompleted
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia
Clinical Trials on Regular School Based Health Asthma Care
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH) and other collaboratorsCompleted
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of Texas at AustinNational Institute of Nursing Research (NINR)Completed
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)CompletedAsthmaUnited States
-
National Jewish HealthUniversity of ArizonaEnrolling by invitationAsthma in ChildrenUnited States
-
Arkansas Children's Hospital Research InstituteNational Heart, Lung, and Blood Institute (NHLBI); University of ArkansasCompletedQuality of Life | Asthma | ChildrenUnited States
-
King Edward Medical UniversityCompletedSchool Mental Health Training of TeachersPakistan
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI); Halcyon Hill FoundationCompleted
-
Unity Health TorontoToronto District School BoardCompletedEducational AchievementCanada